Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C

Eric C. Bascuñan-Castillo, Robert P. Erickson, Christy M. Howison, Robert J. Hunter, Randall H. Heidenreich, Chad Hicks, Theodore "Ted" Trouard, Robert J. Gillies

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Niemann-Pick C disease (NPC) is an irreversible neurodegenerative disorder without current treatment. It is the result of deficient intracellular cholesterol movement. We investigated the effects of tamoxifen and vitamin E (D-alpha tocopherol) treatment on patterns of weight loss and motor function in the mouse model of Niemann-Pick C disease (Npc1-/- mice). Tamoxifen has multiple metabolic effects, including reducing oxidative damage, while vitamin E primarily has this property. Npc1-/- mice were identified and treatment was initiated at an approximate age of 21 days. Tamoxifen suspended in peanut oil was administered via intraperitoneal injection (weekly, at a dose calculated to deliver 0.023 μg/g/day). Vitamin E (25 IU) was administered orally via gavage once a week. Weight loss and Rota-Rod performance were analyzed by using Kaplan-Meyer survival curves. Tamoxifen treatment by itself significantly delayed weight loss (an endpoint of neurodegeneration) in male and female mice compared to untreated controls. Motor function was evaluated by performance on a Rota-Rod. Tamoxifen maintained Rota-Rod performance for about an extra week. Vitamin E treatment significantly delayed weight loss in females only. Rota-Rod performance was maintained slightly longer in mice treated with vitamin E. Simultaneous use of both treatments did not delay weight loss longer than tamoxifen-only treatment but had a greater effect than either treatment alone on Rota-Rod performance and demonstrated a significant positive effect on the early "learning curve" portion of the Rota-Rod evaluations. We found significant but relatively small improvements in rate of disease progression by treating Npc1-/- mice with tamoxifen and/or vitamin E. Some sex differences in response and an early improvement in Rota-Rod performance suggest areas for further study.

Original languageEnglish (US)
Pages (from-to)461-467
Number of pages7
JournalJournal of Applied Genetics
Volume45
Issue number4
StatePublished - 2004

Fingerprint

Tamoxifen
Vitamin E
Weight Loss
Niemann-Pick Diseases
Therapeutics
alpha-Tocopherol
Learning Curve
Intraperitoneal Injections
Vitamin D
Sex Characteristics
Neurodegenerative Diseases
Disease Progression
Cholesterol

Keywords

  • Mice
  • Neurodegeneration
  • Niemann-Pick C
  • Rota-Rod
  • Tamoxifen
  • Vitamin E

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Genetics

Cite this

Bascuñan-Castillo, E. C., Erickson, R. P., Howison, C. M., Hunter, R. J., Heidenreich, R. H., Hicks, C., ... Gillies, R. J. (2004). Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C. Journal of Applied Genetics, 45(4), 461-467.

Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C. / Bascuñan-Castillo, Eric C.; Erickson, Robert P.; Howison, Christy M.; Hunter, Robert J.; Heidenreich, Randall H.; Hicks, Chad; Trouard, Theodore "Ted"; Gillies, Robert J.

In: Journal of Applied Genetics, Vol. 45, No. 4, 2004, p. 461-467.

Research output: Contribution to journalArticle

Bascuñan-Castillo, EC, Erickson, RP, Howison, CM, Hunter, RJ, Heidenreich, RH, Hicks, C, Trouard, TT & Gillies, RJ 2004, 'Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C', Journal of Applied Genetics, vol. 45, no. 4, pp. 461-467.
Bascuñan-Castillo EC, Erickson RP, Howison CM, Hunter RJ, Heidenreich RH, Hicks C et al. Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C. Journal of Applied Genetics. 2004;45(4):461-467.
Bascuñan-Castillo, Eric C. ; Erickson, Robert P. ; Howison, Christy M. ; Hunter, Robert J. ; Heidenreich, Randall H. ; Hicks, Chad ; Trouard, Theodore "Ted" ; Gillies, Robert J. / Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C. In: Journal of Applied Genetics. 2004 ; Vol. 45, No. 4. pp. 461-467.
@article{4ed7bb2489ba4367bdc19f88cc586763,
title = "Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C",
abstract = "Niemann-Pick C disease (NPC) is an irreversible neurodegenerative disorder without current treatment. It is the result of deficient intracellular cholesterol movement. We investigated the effects of tamoxifen and vitamin E (D-alpha tocopherol) treatment on patterns of weight loss and motor function in the mouse model of Niemann-Pick C disease (Npc1-/- mice). Tamoxifen has multiple metabolic effects, including reducing oxidative damage, while vitamin E primarily has this property. Npc1-/- mice were identified and treatment was initiated at an approximate age of 21 days. Tamoxifen suspended in peanut oil was administered via intraperitoneal injection (weekly, at a dose calculated to deliver 0.023 μg/g/day). Vitamin E (25 IU) was administered orally via gavage once a week. Weight loss and Rota-Rod performance were analyzed by using Kaplan-Meyer survival curves. Tamoxifen treatment by itself significantly delayed weight loss (an endpoint of neurodegeneration) in male and female mice compared to untreated controls. Motor function was evaluated by performance on a Rota-Rod. Tamoxifen maintained Rota-Rod performance for about an extra week. Vitamin E treatment significantly delayed weight loss in females only. Rota-Rod performance was maintained slightly longer in mice treated with vitamin E. Simultaneous use of both treatments did not delay weight loss longer than tamoxifen-only treatment but had a greater effect than either treatment alone on Rota-Rod performance and demonstrated a significant positive effect on the early {"}learning curve{"} portion of the Rota-Rod evaluations. We found significant but relatively small improvements in rate of disease progression by treating Npc1-/- mice with tamoxifen and/or vitamin E. Some sex differences in response and an early improvement in Rota-Rod performance suggest areas for further study.",
keywords = "Mice, Neurodegeneration, Niemann-Pick C, Rota-Rod, Tamoxifen, Vitamin E",
author = "Bascu{\~n}an-Castillo, {Eric C.} and Erickson, {Robert P.} and Howison, {Christy M.} and Hunter, {Robert J.} and Heidenreich, {Randall H.} and Chad Hicks and Trouard, {Theodore {"}Ted{"}} and Gillies, {Robert J.}",
year = "2004",
language = "English (US)",
volume = "45",
pages = "461--467",
journal = "Journal of Applied Genetics",
issn = "1234-1983",
publisher = "Springer Berlin",
number = "4",

}

TY - JOUR

T1 - Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C

AU - Bascuñan-Castillo, Eric C.

AU - Erickson, Robert P.

AU - Howison, Christy M.

AU - Hunter, Robert J.

AU - Heidenreich, Randall H.

AU - Hicks, Chad

AU - Trouard, Theodore "Ted"

AU - Gillies, Robert J.

PY - 2004

Y1 - 2004

N2 - Niemann-Pick C disease (NPC) is an irreversible neurodegenerative disorder without current treatment. It is the result of deficient intracellular cholesterol movement. We investigated the effects of tamoxifen and vitamin E (D-alpha tocopherol) treatment on patterns of weight loss and motor function in the mouse model of Niemann-Pick C disease (Npc1-/- mice). Tamoxifen has multiple metabolic effects, including reducing oxidative damage, while vitamin E primarily has this property. Npc1-/- mice were identified and treatment was initiated at an approximate age of 21 days. Tamoxifen suspended in peanut oil was administered via intraperitoneal injection (weekly, at a dose calculated to deliver 0.023 μg/g/day). Vitamin E (25 IU) was administered orally via gavage once a week. Weight loss and Rota-Rod performance were analyzed by using Kaplan-Meyer survival curves. Tamoxifen treatment by itself significantly delayed weight loss (an endpoint of neurodegeneration) in male and female mice compared to untreated controls. Motor function was evaluated by performance on a Rota-Rod. Tamoxifen maintained Rota-Rod performance for about an extra week. Vitamin E treatment significantly delayed weight loss in females only. Rota-Rod performance was maintained slightly longer in mice treated with vitamin E. Simultaneous use of both treatments did not delay weight loss longer than tamoxifen-only treatment but had a greater effect than either treatment alone on Rota-Rod performance and demonstrated a significant positive effect on the early "learning curve" portion of the Rota-Rod evaluations. We found significant but relatively small improvements in rate of disease progression by treating Npc1-/- mice with tamoxifen and/or vitamin E. Some sex differences in response and an early improvement in Rota-Rod performance suggest areas for further study.

AB - Niemann-Pick C disease (NPC) is an irreversible neurodegenerative disorder without current treatment. It is the result of deficient intracellular cholesterol movement. We investigated the effects of tamoxifen and vitamin E (D-alpha tocopherol) treatment on patterns of weight loss and motor function in the mouse model of Niemann-Pick C disease (Npc1-/- mice). Tamoxifen has multiple metabolic effects, including reducing oxidative damage, while vitamin E primarily has this property. Npc1-/- mice were identified and treatment was initiated at an approximate age of 21 days. Tamoxifen suspended in peanut oil was administered via intraperitoneal injection (weekly, at a dose calculated to deliver 0.023 μg/g/day). Vitamin E (25 IU) was administered orally via gavage once a week. Weight loss and Rota-Rod performance were analyzed by using Kaplan-Meyer survival curves. Tamoxifen treatment by itself significantly delayed weight loss (an endpoint of neurodegeneration) in male and female mice compared to untreated controls. Motor function was evaluated by performance on a Rota-Rod. Tamoxifen maintained Rota-Rod performance for about an extra week. Vitamin E treatment significantly delayed weight loss in females only. Rota-Rod performance was maintained slightly longer in mice treated with vitamin E. Simultaneous use of both treatments did not delay weight loss longer than tamoxifen-only treatment but had a greater effect than either treatment alone on Rota-Rod performance and demonstrated a significant positive effect on the early "learning curve" portion of the Rota-Rod evaluations. We found significant but relatively small improvements in rate of disease progression by treating Npc1-/- mice with tamoxifen and/or vitamin E. Some sex differences in response and an early improvement in Rota-Rod performance suggest areas for further study.

KW - Mice

KW - Neurodegeneration

KW - Niemann-Pick C

KW - Rota-Rod

KW - Tamoxifen

KW - Vitamin E

UR - http://www.scopus.com/inward/record.url?scp=10444258232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10444258232&partnerID=8YFLogxK

M3 - Article

C2 - 15523158

AN - SCOPUS:10444258232

VL - 45

SP - 461

EP - 467

JO - Journal of Applied Genetics

JF - Journal of Applied Genetics

SN - 1234-1983

IS - 4

ER -